BIIB vs BMY: Options Risk Comparison

BIOGEN INC. and BRISTOL MYERS SQUIBB CO compared side by side — risk score, IV Rank, edge and earnings. Updated every 30 minutes.

Metric	BIIB	BMY
Risk Score	45	44
Risk Band	MEDIUM	LOW
IV Rank	47.1%	50.5%
IV %	38.5%	29.8%
Edge Score	+2	+6
Price Δ	+0.6%	+0.5%
Next Earnings	2026-07-30	2026-07-30
Sector	Health Care	Health Care

Which has higher options risk?

BIOGEN INC. (BIIB) currently carries the higher options risk score (45 vs 44 for BMY) — meaning more active catalysts that can drive an overnight move. For selling option premium, BRISTOL MYERS SQUIBB CO (BMY) has the better edge score (+6) — a stronger blend of high IV Rank and low risk.

Risk score (0–100) reflects active catalysts — earnings, legal, SEC filings and news. Edge score = IV Rank − risk score; higher is better for selling premium.

Run a full scan on each — free

Scan BIIB → Scan BMY →

BIIB risk pages

BIIB overview BIIB IV / options BIIB earnings BMY overview BMY IV / options BMY earnings

More Health Care comparisons

BIIB vs ABT BIIB vs ABBV BIIB vs A BIIB vs ALGN BIIB vs AMGN BIIB vs BAX BIIB vs BDX BIIB vs TECH

TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer